SGYP:
Analysis & Opinions
-
January 29, 2013
Synergy Pharmaceuticals Inc. (SGYP) recently initiated a phase Ib study on its inflammatory bowel disease (IBD) ...
-
January 17, 2013
Synergy Pharmaceuticals Inc.'s (SGYP) stockholders recently approved Synergy Pharma's merger with Callisto ...
-
January 03, 2013
Synergy Pharmaceuticals (SGYP) recently presented positive results from a phase IIb/III study on its chronic ...
-
December 31, 2012
Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients ...
-
August 28, 2012
Synergy Pharmaceuticals Inc. (SGYP) recently acquired all assets related to FV-100, an oral nucleoside analogue, ...
